Delta-Fly Pharma, Inc.
Develops innovative, gentle anticancer agents with reduced side effects for cancer patients.
4598 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 徳島市川内町宮島錦野３７番地の５
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Delta-Fly Pharma, Inc. is a biopharmaceutical company specializing in the research and development of anticancer agents. The company utilizes its proprietary "Module Drug Development" concept to create innovative and "gentle" cancer treatments designed to have reduced side effects and be available at a reasonable price. Its development pipeline focuses on small molecule and RNA therapeutics for various cancers, including Acute Myeloid Leukemia. Delta-Fly Pharma's mission is to develop medicines that benefit cancer patients and society through its unique drug discovery approach.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Delta-Fly Pharma, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-27 08:44 |
Regulatory News Service
臨時報告書
|
Japanese | 24.4 KB | |
| 2025-06-27 08:39 |
Regulatory News Service
内部統制報告書－第15期(2024/04/01－2025/03/31)
|
Japanese | 23.0 KB | |
| 2025-06-27 08:34 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2025-06-27 08:30 |
Annual Report
有価証券報告書－第15期(2024/04/01－2025/03/31)
|
Japanese | 1.1 MB | |
| 2025-04-14 08:30 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 289.0 KB | |
| 2024-11-14 07:39 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB | |
| 2024-11-14 07:36 |
Interim Report
半期報告書－第15期(2024/04/01－2025/03/31)
|
Japanese | 180.2 KB | |
| 2024-10-07 08:00 |
Regulatory News Service
臨時報告書
|
Japanese | 22.6 KB | |
| 2024-09-20 08:00 |
Prospectus
有価証券届出書（組込方式）
|
Japanese | 326.2 KB | |
| 2024-09-11 08:00 |
Regulatory News Service
臨時報告書
|
Japanese | 22.8 KB | |
| 2024-06-28 08:31 |
Regulatory News Service
臨時報告書
|
Japanese | 23.5 KB | |
| 2024-06-28 08:28 |
Regulatory News Service
確認書
|
Japanese | 8.8 KB | |
| 2024-06-28 08:25 |
Regulatory News Service
内部統制報告書－第14期(2023/04/01－2024/03/31)
|
Japanese | 22.6 KB | |
| 2024-06-28 08:21 |
Annual Report
有価証券報告書－第14期(2023/04/01－2024/03/31)
|
Japanese | 979.5 KB | |
| 2024-02-13 07:20 |
Regulatory News Service
確認書
|
Japanese | 8.9 KB |
Automate Your Workflow. Get a real-time feed of all Delta-Fly Pharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Delta-Fly Pharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
